Bakuchiol for Menopausal Skin: Does It Work?

Bakuchiol has become one of the most searched skincare ingredients for menopausal skin - and there are real reasons for that. It is gentle, plant-derived, and backed by early clinical evidence that places it alongside retinol for certain skin concerns. But “popular” and “proven” are not the same thing, and menopausal skin deserves more than a trend.

This blog breaks down what the science actually says about bakuchiol for menopausal skin, where it has genuine merit, where its limitations lie, and what the clinical evidence points to instead. One thing to say clearly from the outset: INKEY does not currently sell a bakuchiol product. What we do make are clinically proven alternatives - our Starter Retinol (£12), Advanced 0.2% Retinal (£15), and Bio-Active Ceramide Moisturiser (£19) - that address the same menopausal skin concerns with a more extensive clinical evidence base behind them.

Here is what this blog covers: what menopause does to skin, why bakuchiol appeals to that skin, what the clinical evidence says, where it falls short, what to look for in an effective menopausal skincare active, and which INKEY formulations address those needs directly.

What Happens to Your Skin During Menopause?

To understand why ingredient choices matter so much during menopause, it helps to understand what is actually happening beneath the surface. Menopause is not simply a natural ageing process accelerating - it is a distinct hormonal event with direct, measurable effects on skin structure, function, and resilience.

The central driver is oestrogen decline. As oestrogen drops during perimenopause and menopause, the skin loses its main hormonal support system. Oestrogen plays a significant role in collagen synthesis, moisture retention, and inflammatory regulation. When it falls, the consequences are rapid and visible. According to research cited by the Cleveland Clinic, collagen production can decline by up to 30% in the first five years following menopause - a rate far exceeding standard chronological ageing.

This collagen loss manifests as thinner, less elastic skin. Fine lines deepen faster. Sagging appears sooner. The structural scaffolding of the skin is depleted at a pace that makes ingredient efficacy and speed of results genuinely important considerations - not simply nice-to-haves.

Moisture retention is compromised at the same time. Oestrogen helps regulate the skin’s natural production of hyaluronic acid and ceramides - both of which are critical to the skin barrier’s ability to hold water. As oestrogen declines, the skin struggles to retain moisture. Dryness, tightness, and itching follow. This is not simply about drinking more water or applying a heavier moisturiser. It is a structural barrier issue that requires targeted ingredients to address.

Menopausal skin also becomes more sensitive and reactive. The skin barrier is more easily disrupted, meaning that active ingredients - even well-tolerated ones - can cause more noticeable responses during the adjustment period. For many women, this is precisely the reason bakuchiol becomes appealing: the promise of retinol-like results without retinol-like irritation.

Hyperpigmentation becomes a growing concern. Hormonal fluctuations during the menopausal transition trigger uneven melanin distribution, leading to dark spots and an increasingly uneven skin tone. And then there are hot flushes - repeated cycles of skin flushing and localised inflammation that, over time, contribute to barrier disruption and persistent redness.

The five key ways menopause changes skin, summarised:

Collagen loss accelerates - up to 30% in the first five years, leading to deeper lines and visible laxity.
Moisture retention declines - ceramide and hyaluronic acid production drops as oestrogen falls.
Sensitivity increases - a compromised barrier reacts more easily to actives and environmental triggers.
Hyperpigmentation worsens - hormonal fluctuations drive uneven melanin distribution and dark spots.
Hot flushes disrupt the barrier - repeated flushing cycles create inflammation and redness over time.

This is the biological backdrop against which every ingredient decision should be made. And it is what makes the appeal of bakuchiol so understandable - as well as what ultimately reveals its limitations. For anyone exploring the anti-ageing concern category, the science of menopausal skin makes it clear that ingredient specificity matters more here than in almost any other skincare context.

Understanding the biological reality of menopausal skin makes it easier to see why bakuchiol has attracted so much attention - and why its appeal is not without foundation.

Why Bakuchiol Appeals to Menopausal Skin (and When It Makes Sense)

Bakuchiol is not a gimmick. It is worth being clear about that. It is a plant-derived compound extracted from the seeds and leaves of the Psoralea corylifolia plant - better known as babchi - and has a documented history in Ayurvedic and traditional Chinese medicine spanning centuries. The modern skincare industry’s interest in it is not simply trend-chasing. There is a mechanism of action that explains why it behaves as it does, and why menopausal skin, in particular, is drawn to it.

At a molecular level, bakuchiol activates retinol-like gene expression pathways in the skin. It stimulates collagen production and skin cell renewal without being a retinoid. This matters because it means bakuchiol delivers a retinol-adjacent benefit profile while bypassing the mechanisms that make retinol difficult for sensitive or barrier-compromised skin to tolerate. A pharmacological review published on PMC/NIH confirms both the mechanism of action and bakuchiol’s anti-inflammatory and antioxidant properties - two qualities that are particularly relevant for menopausal skin.

Three core reasons explain why menopausal skin is drawn to bakuchiol specifically:

Very low irritation potential - there is no adjustment period of the kind associated with retinol. No peeling, stinging, or dryness spike in the early weeks. For skin that is already reactive and moisture-compromised, this is a meaningful advantage.
Anti-inflammatory and antioxidant properties - menopausal skin has lost some of oestrogen’s natural anti-inflammatory protection. Bakuchiol can partially compensate through its own anti-inflammatory activity, helping to calm reactive skin and reduce the cumulative redness associated with hot flushes.
No photosensitivity increase - unlike retinol, bakuchiol does not make skin more sensitive to UV. It can be used both morning and evening without requiring additional precautions beyond a daily SPF.

Bakuchiol also does not exacerbate dryness the way retinol can in the early weeks of use. When skin is already struggling to retain moisture due to oestrogen decline, an active that strips further hydration is the last thing it needs. Bakuchiol sidesteps this entirely.

It is also worth noting that bakuchiol is widely considered safe for use during pregnancy and breastfeeding - a relevant consideration for women in the perimenopause transition who may still be navigating reproductive health decisions alongside skincare choices.

For a full breakdown of how bakuchiol works at an ingredient level, our bakuchiol guide covers the science in depth.

The appeal of bakuchiol is real and well-founded. The question is whether that appeal translates into clinical outcomes strong enough to match what menopausal skin actually needs. That is what the evidence shows - and where the picture becomes more nuanced.

What the Science Actually Says About Bakuchiol for Menopausal Skin

The most significant piece of clinical evidence for bakuchiol is the 2018 randomised controlled trial published in the British Journal of Dermatology. Forty-four participants used either 0.5% bakuchiol or 0.5% retinol twice daily for 12 weeks. The result: bakuchiol performed comparably to retinol in reducing the visible appearance of wrinkles and hyperpigmentation - with significantly fewer side effects. Less dryness, less peeling, less stinging. This remains the landmark study for bakuchiol, and it is legitimately compelling.

Harvard Health’s review of the study describes bakuchiol as “promising but unproven” - acknowledging the genuine results while flagging the limited participant pool. Forty-four participants is a small cohort compared to retinol’s decades of multi-trial, large-scale research. That context matters.

The evidence base is growing. A 2026 randomised controlled trial, published on PMC, examining a combination of genistein and bakuchiol showed further promising results for skin renewal and anti-ageing outcomes. The trajectory of bakuchiol research is positive. But “growing” and “established” are not the same thing.

From a menopausal skin perspective specifically, bakuchiol’s antioxidant and anti-inflammatory properties carry particular weight. Oestrogen has natural anti-inflammatory effects on skin. As oestrogen declines, menopausal skin loses a layer of protection it previously took for granted. Bakuchiol’s anti-inflammatory activity can partially fill that gap - not as a hormonal replacement, but as a complementary support. This is one area where bakuchiol genuinely addresses a menopause-specific need.

The mechanism of action - activating retinol-like gene expression pathways - means bakuchiol stimulates the same collagen-supporting processes as retinol, but more gradually. This gradual pace is a double-edged quality. It reduces irritation risk. It also means slower results.

The timeline reality is important:

Bakuchiol: 8 to 12 weeks of consistent daily use for meaningful visible improvement in fine lines and texture.
Well-formulated retinol: Clinically proven to smooth fine lines from 7 days.
Retinal: Clinically proven to visibly reduce deep wrinkles in 1 week.

For menopausal skin, where collagen loss is accelerating at a documented rate, the question of how quickly an active works is not trivial. The Cleveland Clinic’s review of bakuchiol acknowledges its benefits while reinforcing that retinol remains the more established and extensively studied active. For a deeper understanding of why retinol occupies that position, our retinol ingredient guide covers the full evidence base.

The science validates bakuchiol’s promise. It does not yet validate it as the optimal choice for menopausal skin seeking the strongest, fastest, most clinically supported results.

"Bakuchiol is promising but unproven - it works but it needs more study.” - Harvard Health

Understanding what the science shows is the necessary foundation for understanding where bakuchiol’s limitations begin - and that is where the most important decisions for menopausal skin get made.

The Limitations of Bakuchiol for Menopausal Skin

Bakuchiol deserves its reputation as a gentle, effective ingredient. This section is not about dismissing it. It is about being honest about what the clinical evidence actually supports - and where the evidence points elsewhere.

The most significant limitation is the evidence base itself. The landmark 2018 study involved 44 participants over 12 weeks. Retinol and retinal have been the subject of decades of research, across hundreds of studies, with thousands of participants. The comparison is not close. When choosing between an active with strong early promise and one with an extensive, replicable evidence base, that disparity matters - particularly for menopausal skin, where the stakes of getting the skincare routine right are high.

Results with bakuchiol are gradual. Eight to twelve weeks for meaningful visible change. For skin that is losing collagen at an accelerated rate, a slower-acting active is not necessarily the wrong choice - but it is worth weighing against faster-acting alternatives, especially when those alternatives are now formulated to address the tolerability concerns that made bakuchiol appealing in the first place.

Bakuchiol also cannot fully compensate for the collagen-depleting effect of oestrogen loss. It stimulates collagen-supporting gene pathways - but at a gentler rate than clinical retinoids. The deeper the collagen deficit, the more important it becomes to use an active with the clinical evidence to address it at the pace and depth menopausal skin requires.

The PMC pharmacological review that confirms bakuchiol’s mechanism and properties also underscores the limitation: most of the clinical evidence comes from a limited number of studies. The science is real. The evidence base is not yet expansive.

What bakuchiol cannot fully address for menopausal skin:

Speed of results - 8 to 12 weeks versus 7 days for a well-formulated retinoid.
Depth of collagen support - it stimulates the pathway gradually; retinoids do so more directly and at a clinically established rate.
Breadth of evidence - 44 participants versus decades of multi-trial retinoid research.
Hyperpigmentation - bakuchiol has shown some effect on tone, but retinoids have a stronger, better-documented record on cell renewal and pigmentation correction.

The tolerability gap that once made retinol feel out of reach for sensitive and menopausal skin is one that modern formulation has specifically addressed. Our Starter Retinol is clinically tested with 95% of participants experiencing zero irritation. That single data point directly responds to the concern that most often drives people towards bakuchiol in the first place. For a full side-by-side look at how bakuchiol and retinol compare, our dedicated guide covers the comparison in detail.

With a clear picture of bakuchiol’s strengths and limitations, the practical question becomes: what should menopausal skin actually look for in an effective active?

What to Look for in a Serum for Menopausal Skin

Choosing a serum for menopausal skin is not simply about finding the most powerful active available. It is about matching clinical efficacy to the specific vulnerabilities of skin that is losing collagen, struggling with moisture retention, becoming more reactive, and dealing with uneven tone - all at the same time.

Here is what the evidence supports as the core criteria.

Collagen-stimulating actives with clinical evidence. Retinol, retinal, and peptides all have documented clinical backing for collagen stimulation. When evaluating any serum for menopausal skin, the question to ask is not “does this ingredient work in theory?” but “what clinical data exists, with how many participants, over what period, showing what results?” Ingredients with large, replicable evidence bases offer a more reliable foundation than those backed by a single study - however promising that study may be. Our retinol ingredient guide breaks down why retinol remains the gold-standard active for anti-ageing and what the evidence behind it actually shows.

Barrier-supportive formulation. An active ingredient that strips the skin barrier worsens the very problems menopausal skin is already contending with. Any effective serum for menopausal skin should be formulated alongside ceramides, lipids, or squalane - ingredients that reinforce the barrier while the active works. A product that only delivers the active without supporting the barrier is an incomplete solution.

Tolerability engineering. For menopausal skin, the traditional retinol adjustment period - dryness, peeling, sensitivity in the early weeks - can feel more pronounced. This is one of the primary reasons bakuchiol has become popular. But modern formulation has directly addressed this. Encapsulated or slow-release retinoid complexes deliver the active gradually to the skin, reducing irritation without compromising efficacy. The adjustment period becomes manageable. The results remain clinically meaningful.

Anti-inflammatory support. Oestrogen’s decline removes a layer of the skin’s natural anti-inflammatory protection. Hot flushes add repeated cycles of inflammation on top of that. A serum that includes genuinely calming actives - such as bisabolol or SymRelief - does not just soothe in the moment. It supports the skin’s ability to tolerate an active ingredient over time, reducing the likelihood of reactive episodes.

Hyperpigmentation support. Menopausal skin is more prone to dark spots and uneven tone due to hormonal fluctuations in melanin distribution. An ingredient that addresses both cell renewal and tone simultaneously - retinol and retinal both do this - covers more ground with a single active than one focused exclusively on texture or lines.

Realistic timeline expectations. This is a practical consideration, not a criticism of any particular ingredient. Bakuchiol: 8 to 12 weeks. A well-formulated retinol: visible results from 7 days. Retinal: visible wrinkle reduction from 1 week. For menopausal skin where changes are happening quickly, timeline matters. As Northwestern Medicine notes, the skin changes associated with menopause are not gradual - they accelerate in the first years following the transition. The anti-ageing collection contains options that address the full range of menopausal skin needs.

With these criteria in place, the evaluation of any product for menopausal skin becomes more straightforward. The question is not “is this ingredient popular?” It is “does this formulation meet the clinical bar that menopausal skin actually requires?”

The INKEY Alternatives to Bakuchiol for Menopausal Skin

INKEY does not currently sell a bakuchiol product. What the formulations below do is address the same concerns that drive people to bakuchiol - sensitivity, barrier compromise, collagen loss, uneven tone - with clinical data specific to each product.

Starter Retinol Serum - £12

Shop the Starter Retinol

Best for: Retinol beginners, sensitive and menopausal skin, anyone who has previously found retinol too harsh to use consistently.

The Starter Retinol is built specifically around the tolerability problem. Its Dual-Retinoid complex combines 1% Granactive Pro+ (encapsulated Granactive Retinoid) with 0.01% Retinal - a formulation proven to be 2x more effective than standard retinol. The encapsulation means the active is delivered gradually to the skin, reducing the irritation peak that characterises traditional retinol formulations.

The clinical data is the reason this product directly answers the case for bakuchiol. 95% of users experienced zero irritation. That figure matters because the primary driver of bakuchiol’s popularity is the assumption that retinol is too harsh for reactive, menopausal skin. This data challenges that assumption directly.

Beyond tolerability: clinically proven to smooth fine lines from 7 days. 90% saw significant improvement in wrinkles in 4 weeks. 86% agreed skin tone looked more even. 92% said skin felt noticeably smoother.

The formulation also includes SymRelief for calming, Amisol Trio for barrier lipids, and Squalane for hydration - three ingredients that directly address the barrier compromise and moisture deficit associated with menopausal skin.

Use PM only, starting at 2 to 3 nights per week. If skin is particularly reactive in the first couple of weeks, the moisture sandwich method - a thin layer of moisturiser before and after the retinol - reduces sensitivity further.

Advanced 0.2% Retinal Serum - £15

Shop the Advanced 0.2% Retinal

Best for: Experienced actives users, those stepping up from bakuchiol, menopausal skin seeking faster and deeper anti-ageing results.

Retinal sits one conversion step closer to retinoic acid than retinol - and that proximity makes a measurable difference. Retinal works up to 11x faster than standard retinol. For menopausal skin where collagen is depleting at pace, that speed is not a luxury. It is a clinical advantage.

Clinically proven to visibly reduce deep wrinkles in 1 week. 85% saw firmer, more lifted-looking skin in 4 weeks. 80% saw visible improvement in skin radiance. The formulation also contains Sirtalice, which delivers visible firming in 30 minutes.

This is the product for menopausal skin that has been using bakuchiol but wants stronger, faster results - or for those who are already comfortable with retinoids and want to step up. It is not the starting point for retinoid beginners. Use PM only, building frequency gradually as tolerance is established.

Bio-Active Ceramide Moisturiser - £19

Shop the Bio-Active Ceramide Moisturiser

Best for: Menopausal skin seeking retinoid-free anti-ageing, pairing with a retinoid for maximum barrier support, sensitive skin that cannot yet tolerate actives.

The Bio-Active Ceramide Moisturiser functions both as a standalone anti-ageing product and as an essential pairing with either retinoid option. Clinically proven to reduce 6 signs of ageing in 28 days. A 6-time consecutive Allure Best of Beauty Award winner.

Its Bioactive Ceramide NP repairs and strengthens the skin barrier - directly addressing the ceramide depletion that occurs as oestrogen declines during menopause. This is not simply a moisturising ingredient. It is a barrier-rebuilding active that targets one of the most fundamental structural changes menopausal skin undergoes.

Gransil Blur technology delivers an immediate, visible result - fine lines are blurred on application, giving an optical softening effect that complements the longer-term clinical benefits.

For menopausal skin that cannot use retinoids - due to medication interactions, pregnancy history, or personal preference - this moisturiser is a standalone clinically proven anti-ageing option.

Not sure which product is the right starting point? Take our Skincare Quiz and we’ll build a routine personalised to your skin in under two minutes.

How to Build a Menopausal Skincare Routine

The products above are most effective when used as part of a structured routine. Below are three frameworks for different skin situations and entry points.

Routine 1: For Menopausal Skin New to Retinoids

AM:

Cleanser
Hydrating serum - apply to damp skin for maximum moisture absorption
Bio-Active Ceramide Moisturiser (£19)
SPF - essential every morning without exception

PM (2-3 nights per week to begin):

Cleanser
Hydrating serum
Starter Retinol (£12) - pea-sized amount, applied across the face
Bio-Active Ceramide Moisturiser (£19)

Tip: If skin feels reactive in the first two weeks, use the moisture sandwich method - apply a thin layer of moisturiser before and after the retinol. This slows the delivery of the active slightly and significantly reduces the chance of irritation.

Routine 2: For Menopausal Skin Stepping Up from Bakuchiol

AM:

Cleanser
Hydrating serum
Bio-Active Ceramide Moisturiser (£19)
SPF

PM (build frequency gradually):

As tolerance builds over four to six weeks, frequency can increase. Begin at two to three nights per week and progress from there.

Routine 3: Retinoid-Free Menopausal Routine

AM and PM:

Cleanser
Hydrating serum - apply to damp skin
Bio-Active Ceramide Moisturiser (£19)

For menopausal skin that cannot or prefers not to use retinoids, the Bio-Active Ceramide Moisturiser’s Bioactive Ceramide NP and Gransil Blur technology deliver clinically proven anti-ageing results in a fully retinoid-free format.

General tips for introducing actives to menopausal skin:

Introduce retinoids slowly - start at 2 to 3 nights per week and build tolerance over 4 to 8 weeks. There is no benefit to accelerating this.
Always follow retinoids with a moisturiser - barrier support is non-negotiable for menopausal skin. It is not optional.
SPF every morning without exception - retinoids increase photosensitivity, and menopausal skin is already more vulnerable to UV-triggered hyperpigmentation. No SPF means the active is working against itself.
Hydration first - apply hydrating serums to damp skin before actives for maximum absorption. Dry skin absorbs less effectively.

For a full guide to introducing retinoids safely, our retinol ingredient page covers the process in detail. And if you want a routine built specifically for your skin, our Skincare Quiz does exactly that.

Frequently Asked Questions

Is bakuchiol good for menopausal skin?

Yes - with caveats. Bakuchiol has anti-inflammatory and antioxidant properties that suit reactive menopausal skin, and it activates collagen-supporting gene pathways without irritation. However, the clinical evidence base is limited compared to retinoids, and results take 8 to 12 weeks. For menopausal skin where collagen loss is accelerating, a well-formulated retinoid with strong clinical backing may deliver stronger, faster results.

Can I use bakuchiol instead of retinol during menopause?

You can. Bakuchiol is a reasonable choice if you want to avoid retinoids - particularly if your skin is very reactive. If there is no specific reason to avoid retinol, the clinical evidence places retinol and retinal ahead for speed and depth of anti-ageing results. See our full comparison of bakuchiol and retinol for a detailed breakdown.

Is retinol safe for menopausal skin?

Yes - when formulated correctly. The key is starting with a gentle, slow-release formulation and introducing it gradually. Our Starter Retinol (£12) is clinically tested for sensitive skin, with 95% of users experiencing zero irritation. That is specifically the concern menopausal skin most often has about retinol - and this data addresses it directly.

What is the best serum for menopausal skin?

It depends on skin tolerance and goals. For retinoid beginners: the Starter Retinol (£12) offers clinically proven results with a tolerability profile designed for sensitive skin. For those wanting faster, deeper anti-ageing results: the Advanced 0.2% Retinal (£15). For retinoid-free anti-ageing: the Bio-Active Ceramide Moisturiser (£19), clinically proven to reduce 6 signs of ageing in 28 days.

How long does bakuchiol take to work on menopausal skin?

Typically 8 to 12 weeks of consistent daily use for meaningful visible improvement in fine lines and texture. This is one of bakuchiol’s primary limitations compared to well-formulated retinoids, which show visible results from 7 days.

Can I use bakuchiol and retinol together?

With care - both activate overlapping pathways, so using both simultaneously is not typically necessary and can increase irritation risk without additional benefit. If stepping up from bakuchiol to retinol, the cleaner approach is to introduce the Starter Retinol and gradually reduce bakuchiol use rather than layering both products.

Does INKEY sell bakuchiol?

Not currently. Our Starter Retinol (£12), Advanced 0.2% Retinal (£15), and Bio-Active Ceramide Moisturiser (£19) are formulated to address the same menopausal skin concerns - with strong clinical backing across all three. For broader ingredient background on bakuchiol itself, our bakuchiol guide covers everything you need to know.

What skincare ingredients should I avoid during menopause?

Avoid highly irritating formulations that lack barrier support. Any active that causes prolonged redness, persistent peeling, or significant tightness is disrupting a barrier that menopausal skin is already struggling to maintain. Always introduce new actives slowly - 2 to 3 nights per week to begin - and prioritise hydration and barrier care alongside any active treatment. The goal is effective skin renewal without compromising the barrier that menopausal skin depends on.

Menopausal Skin Deserves More Than a Trend

Bakuchiol is a genuinely effective ingredient. That is worth saying clearly. Its anti-inflammatory and antioxidant properties are well-suited to reactive menopausal skin. Its mechanism of action - activating retinol-like gene pathways without being a retinoid - is scientifically validated. The 2018 British Journal of Dermatology trial is real, and its results are meaningful. Bakuchiol is not hype.

But the evidence base is limited. Results are gradual. And for menopausal skin, where collagen loss is accelerating faster than at any other point in adult life, both the depth and the speed of clinical outcomes matter.

The reason bakuchiol became popular was a reasonable one: retinol felt too harsh. That concern is valid. But modern formulation has specifically addressed it. A slow-release, encapsulated retinoid complex that produces zero irritation in 95% of users is not the retinol that deserved its difficult reputation. It is the evolution of that ingredient - designed precisely for the skin that bakuchiol was trying to serve.

Our Starter Retinol (£12) closes the tolerability gap without closing the door on clinical efficacy. The Advanced 0.2% Retinal (£15) is for those who want to step up. The Bio-Active Ceramide Moisturiser (£19) delivers clinically proven anti-ageing in a retinoid-free format - for those who need or prefer that route.

Menopause changes skin. Rapidly, measurably, and in ways that require a genuinely considered response. The right formulation does not reverse that - but it makes a real, clinically documented difference to how that skin looks, feels, and functions. And that is worth getting right.

Ready to find the right routine for menopausal skin? Take our Skincare Quiz and we’ll build a personalised routine in under two minutes.

Or shop the full anti-ageing collection to explore all options.